Warnex Sells Division, Providing Persistence Capital with Partial Exit

Laval, Québec-based Warnex Inc., a provider of laboratory services to companies in life sciences sectors, has completed the previously announced sale of its bioanalytical services division to privately owned French research firm Biotrial Research S.A.S. The transaction provided a partial exit to Persistance Capital Partners, a Canadian private equity investor focusing on opportunities in the healthcare field.

14 December 2012•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles